Erez Meltzer - 18 Mar 2026 Form 3 Insider Report for Nano-X Imaging Ltd. (NNOX)

Role
Chief Executive Officer, Director
Signature
/s/ Marina Gofman Feler, attorney-in-fact
Issuer symbol
NNOX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 11:31:23 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meltzer Erez Chief Executive Officer, Director C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL /s/ Marina Gofman Feler, attorney-in-fact 18 Mar 2026 0001371973

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NNOX Ordinary shares 60,584 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NNOX Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 40,234 $2.21 Direct F1
holding NNOX Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 300,000 $23.84 Direct F2
holding NNOX Stock Option (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 150,000 $11.52 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
F2 The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
F3 The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Remarks:

Exhibit 24.1 Power of Attorney